The global cell line development market is expected to grow at growth rate of 10.8% to reach USD 6.43 billion by 2025.

Increasing research and development initiatives in oncology area coupled with growing incidence of cancer globally is likely to boost demand for cell lines, leading to market growth. As per the World Health Organizations (WHO), Cancer is considered to be the second leading cause of death worldwide, and was responsible for more than 8.8 million deaths in 2015. Nearly 1 in 6 deaths is due to cancer reported across the globe during the same year. Additionally, rising demand for MAbs-based therapies are considered to be the foremost factors that are anticipated to augment the segment growth. On other side, cell culture or development methods require significant capital investment. For example, manufacturing of mammalian cell under fully validated plant demands 2-4 million USD per year in costs of materials especially for media, 15-20 million USD per year in manufacturing costs and 40-60 million USD to construct a facility. Further, companies has to spend huge cost for getting FDA approval, including production of a bioactive product, proof of consistent performance, and lack of contamination by viruses and DNA. Such high investment would in turn hamper the market growth to some extent.

Market is categorized in terms of products such as Reagents and Media, Equipment, and Accessories and Consumables. Reagents and medial accounted for the largest segment among other, captured USD 1,200 million revenue during the year 2016. In terms of equipment, the market is seen as Incubators, Centrifuges, Bioreactors, Storage equipment, and Microscopes. Incubators and bioreactors are collectively accounted for 48.79% share of the global market in 2016 and are expected to dominate the market in future. Incubators are anticipated to grow with significant growth rate due to rising usage of it in small scale production facilities and in laboratories. It is considered to be the amongst fundamental equipment for the cell line development.

Mammalian and non-mammalian are two sources for the cell line development. Among which, mammalian sources are most widely used and considered to be the largest market all the years. In terms of types, the cell line development market is divided as Recombinant cell lines, Hybridomas, Continuous cell lines and others. Bioproduction, Drug discovery, Toxicity testing, and others are application area for cell line development. Drug discovery segment is considered to be the least revenue generating application segment owing to the low cost coupled with low preference of it in cell line development.

Regionally, North America dominated the market, captured over 35% share of the global market. Rising research and development activities coupled with increasing number of biotechnology industries in the region helped it to grow consistently. Asia Pacific region is likely to grow with the highest CAGR of 15.2% over the forecast period owing to the favorable government initiatives.

Companies such as American Type Culture Collection, Lonza Group, Thermo Fisher Scientific, GE Healthcare, Sigma-Aldrich Corporation, Corning, Inc.  and others are operating in this market. These players are engaged in strategic merger and acquisitions and research and development activities to expand their presence in market.

KEY BENEFITS OF THE REPORT:

• Understanding of the strategies that are being adopted by the key players in this market to stay competitive
• Extensive analysis of the key players dominating the competitive landscape of this market
• In-depth analysis of the key factors are propelling the growth of the global market
• Detailed analysis of the geographic region that will witness the strongest growth
• Granular analysis of the current market scenario and the expected market grow

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

 MARKET, BY PRODUCTS

• Reagents and Media
• Equipment
• Accessories and Consumables

MARKET, BY EQUIPMENT

• Incubators
• Centrifuges
• Bioreactors
• Storage equipment
• Microscopes

MARKET, BY SOURCE

• Mammalian
• Non mammalian

MARKET, BY TYPES

• Recombinant cell lines
• Hybridomas
• Continuous cell lines
• Primary cell lines

MARKET, BY APPLICATION

• Bioproduction
• Drug discovery
• Toxicity testing
• Others

MARKET, BY REGION

• North America
• Europe
• Asia Pacific
• Rest of the World

MARKET, BY COUNTRY

• Further Breakdown of The North America Market
  • U.S.
  • Canada
• Further Breakdown of The Europe Market
  • Germany
  • France
  • Rest of Europe
• Further Breakdown of The APAC Market
  • India
  • China
  • Rest of APAC
• Further Breakdown of The Rest of the World Market
  • Middle East and Africa
  • Latin America